JP2010183921A5 - - Google Patents

Download PDF

Info

Publication number
JP2010183921A5
JP2010183921A5 JP2010127963A JP2010127963A JP2010183921A5 JP 2010183921 A5 JP2010183921 A5 JP 2010183921A5 JP 2010127963 A JP2010127963 A JP 2010127963A JP 2010127963 A JP2010127963 A JP 2010127963A JP 2010183921 A5 JP2010183921 A5 JP 2010183921A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
acid sequence
host cell
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010127963A
Other languages
English (en)
Other versions
JP5081277B2 (ja
JP2010183921A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010183921A publication Critical patent/JP2010183921A/ja
Publication of JP2010183921A5 publication Critical patent/JP2010183921A5/ja
Application granted granted Critical
Publication of JP5081277B2 publication Critical patent/JP5081277B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (7)

  1. 配列番号:2の核酸配列を含む、単離されたポリヌクレオチド。
  2. 配列番号:4のアミノ酸配列を含むポリペプチド、あるいは、配列番号:4のポリペプチドに少なくとも95%同一のポリペプチドであって、IL−1Rファミリーメンバーに結合する前記ポリペプチド、をコードする核酸配列を含む、単離されたポリヌクレオチド。
  3. 配列番号:4のアミノ酸配列を含むポリペプチド、あるいは、配列番号:4のポリペプチドに少なくとも95%同一のポリペプチドであって、IL−1Rファミリーメンバーに結合する前記ポリペプチド、含むポリペプチド。
  4. 請求項1又は2に記載のポリヌクレオチドを含む、発現ベクター。
  5. 請求項4に記載の発現ベクターで形質転換又はトランスフェクションした宿主細胞。
  6. 請求項5に記載の宿主細胞を、ポリペプチドの発現を促進する条件下で培養することを含む、ポリペプチドの製造方法。
  7. 請求項3に記載のポリペプチドを含むオリゴマーポリペプチド。
JP2010127963A 1998-12-14 2010-06-03 IL−1ゼータ、IL−1ゼータスプライス変異体およびXrec2のDNAおよびポリペプチド Expired - Fee Related JP5081277B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11216398P 1998-12-14 1998-12-14
US60/112,163 1998-12-14
US16467599P 1999-11-10 1999-11-10
US60/164,675 1999-11-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000588357A Division JP4562287B2 (ja) 1998-12-14 1999-12-14 IL−1ゼータ、IL−1ゼータスプライス変異体およびXrec2のDNAおよびポリペプチド

Publications (3)

Publication Number Publication Date
JP2010183921A JP2010183921A (ja) 2010-08-26
JP2010183921A5 true JP2010183921A5 (ja) 2010-10-07
JP5081277B2 JP5081277B2 (ja) 2012-11-28

Family

ID=26809644

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000588357A Expired - Fee Related JP4562287B2 (ja) 1998-12-14 1999-12-14 IL−1ゼータ、IL−1ゼータスプライス変異体およびXrec2のDNAおよびポリペプチド
JP2010127963A Expired - Fee Related JP5081277B2 (ja) 1998-12-14 2010-06-03 IL−1ゼータ、IL−1ゼータスプライス変異体およびXrec2のDNAおよびポリペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000588357A Expired - Fee Related JP4562287B2 (ja) 1998-12-14 1999-12-14 IL−1ゼータ、IL−1ゼータスプライス変異体およびXrec2のDNAおよびポリペプチド

Country Status (13)

Country Link
EP (1) EP1141298B1 (ja)
JP (2) JP4562287B2 (ja)
AT (2) ATE428726T1 (ja)
AU (2) AU775128B2 (ja)
CA (2) CA2642146C (ja)
CY (1) CY1105405T1 (ja)
DE (2) DE69932259T2 (ja)
DK (1) DK1141298T3 (ja)
ES (2) ES2325165T3 (ja)
IL (2) IL143361A0 (ja)
NZ (1) NZ512749A (ja)
PT (1) PT1141298E (ja)
WO (1) WO2000036108A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
EP2319929A1 (en) 1998-12-23 2011-05-11 Genentech, Inc. IL-1 related polypeptides
EP1092773A3 (en) * 1999-10-15 2001-08-08 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Polypeptide and uses thereof
WO2016201503A1 (en) * 2015-06-15 2016-12-22 Monash University Il-37 variants
CN106540242B (zh) * 2016-11-24 2019-09-17 中国医学科学院医学实验动物研究所 IL-1F7a的作用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012160A4 (en) * 1997-08-04 2002-10-29 Millennium Pharm Inc TANGO-72 AND TANGO-77 NUCLEIC ACID AND POLYPEPTID MOLECULES
WO1999006426A1 (en) * 1997-08-04 1999-02-11 Millennium Biotherapeutics, Inc. Novel molecules of the tango-77 related protein family and uses thereof

Similar Documents

Publication Publication Date Title
JP2011155981A5 (ja)
MX2012015142A (es) Polipeptidos que tiene actividad beta-glucosidasa y usos del mismo.
EA201201126A1 (ru) Полипептид, обладающий активностью целлобиогидролазы, и его применение
JP2014513951A5 (ja)
MY160897A (en) Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof
NZ604915A (en) Recombinant production of steviol glycosides
WO2014202616A3 (en) Rasamsonia gene and use thereof
JP2012095652A5 (ja)
JP2011530309A5 (ja)
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
MX342664B (es) Celulasas de familia 5 modificada y usos de las mismas.
EA201300058A1 (ru) Полипептид, обладающий бета-глюкозидазной активностью, и его применение
WO2013151670A3 (en) Modified polynucleotides for the production of nuclear proteins
EA201190326A8 (ru) Полипептиды гормона роста и способы их получения и применения
EA201291024A1 (ru) Композиции эндорибонуклеаз и способы их использования
EP2470670A4 (en) COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
MX2011011215A (es) Polipeptido que degrada carbohidratos y usos del mismo.
WO2010135836A8 (en) Novel beta-glucosidase enzymes
WO2013119302A3 (en) Gh61 polypeptide variants and polynucleotides encoding same
JP2010183921A5 (ja)
PH12015500771A1 (en) Novel fc gamma receptor iib variants
EA201300057A1 (ru) Полипептид, обладающий углеводдеградирующей активностью, и его применения
EA201300056A1 (ru) Полипептид с активностью ацетилксиланэстеразы и его применения
JP2014520527A5 (ja)
EP3279320A3 (en) Gh61 polypeptide variants and polynucleotides encoding same